ShailajaB,SwarnaK,AfreenM, 2015.Kumar A. A rapid assay method development and validation for the estimation of Eplerenone in tablets by UV spectrophotometry,Int J Pharm Pharm Sci 7 327 -30
WeinbergerMH,RonikerB,KrauseSL,WeissRJ, 2002.Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension,Am J Hypertens 15 709 -16
BurgessED,LacourciéreY,Ruilope-UriosteLM,OparilS,KleimanJH,KrauseS,RonikerB,MaurathC, 2003.Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension,Clin Pharmacol Ther 25 2388 -404
RogersJK,McMurrayJJ,PocockSJ,ZannadF,KrumH,van VeldhuisenDJ,SwedbergK,ShiH,VincentJ,PittB., 2012.Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations,Circulation -
WhiteWB,DuprezD,St HillaireR,KrauseS,RonikerB,Kuse-HamiltonJ,WeberMA, 2003.Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension,Hypertension 41 1021 -6
StierCT, 2003.Eplerenone: a selective aldosterone blocker,Cardiovascular drug reviews 21 169 -84
EpsteinM., 2003.Aldosterone receptor blockade and the role of eplerenone: evolving perspectives,Nephrol Dial Transplant 18 1984 -92
PittB,RemmeW,ZannadF,NeatonJ,MartinezF,RonikerB,BittmanR,HurleyS,KleimanJ,GatlinM, 2003.Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction,N Engl J Med 348 1309 -21
ZannadF,McMurrayJJ,KrumH,van VeldhuisenDJ,SwedbergK,ShiH,VincentJ,PocockSJ,PittB., 2011.Eplerenone in patients with systolic heart failure and mild symptoms,N Engl J Med 364 11 -21
NainaK,BrajeshM,ShashankS. Development, 2010.and validation of UV-Spectrophotometric determination of Eplerenone in bulk and tablets,Int J Pharm Life Sci 1 231 -3
UvVoetb, .,Pharmaceutical Sciences. -
BanodeV,KhedekarP,TarteP, 2011.Spectrophotometric estimation of Eplerenone in bulk drug and tablets,Int J Chem Tech Res 3 398 -402
RaneV,PatilK,SangshettiJ,YeoleR,ShindeD, 2009.Stability-indicating RP-HPLC method for analysis of Eplerenone in the bulk drug and in a pharmaceutical dosage form,Acta Pharm 21 619 -29
ZhangJY,FastDM,Breau AP, 2003.A validated SPELC-MS/MS assay for Eplerenone and its hydrolyzed metabolite in human urine,J Pharm Biomed Anal 31 103 -15
GuidelineIH, Switzerland 2005.Validation of analytical procedures: text and methodology Q2 (R1), 11 -2